Off-label useSee our Gabapentin safety rating →

Gabapentin for anxiety

Gabapentin (brand name Neurontin) is a seizure and nerve-pain medicine that some clinicians prescribe off-label for anxiety. It is not FDA-approved for any anxiety disorder, and the evidence that it actually helps is limited and mixed — strongest for social anxiety and short-term pre-surgery nerves, and largely untested for generalized anxiety. This page lays out what the research really shows, how gabapentin is typically dosed off-label, and the safety issues that matter most, including a 2019 FDA warning about serious breathing problems.

Is this an FDA-approved use?

No — this is off-label. Off-label prescribing means a doctor legally uses a drug for a condition the FDA never approved it to treat. It is common and can be reasonable, but it also means the FDA has not reviewed gabapentin's safety or effectiveness for anxiety. Gabapentin's approvals are narrow — postherpetic neuralgia and adjunctive (add-on) treatment of partial seizures — and its prodrug gabapentin enacarbil (Horizant) adds restless legs syndrome. Anxiety appears on none of these labels, so any anxiety use rests on a prescriber's judgment and a handful of smaller studies rather than FDA-reviewed trials. FDA-approved: Gabapentin (brand Neurontin) is FDA-approved only for two things: management of postherpetic neuralgia (the nerve pain that lingers after shingles) in adults, and add-on therapy for partial-onset seizures in adults and children 3 and older. The extended-release prodrug gabapentin enacarbil (Horizant) is separately approved for restless legs syndrome and postherpetic neuralgia. Anxiety is not listed on any gabapentin label — so using it for anxiety is off-label.

By the pharmaranks editorial teamReviewed against the FDA drug label and specialty clinical guidelines sourcesUpdated Jul 20, 2026How we research

What the evidence actually shows

The evidence is limited and mixed, and gabapentin is not a first-line anxiety treatment. Randomized trials of gabapentin specifically for anxiety are few and small. The best known is a 1999 placebo-controlled study in 69 people with social phobia (social anxiety disorder), in which flexible doses of 900–3,600 mg/day reduced symptoms more than placebo. Gabapentin has also beaten placebo for short-term pre-surgery (perioperative) anxiety, mainly at doses above 600 mg. For generalized anxiety disorder (GAD) — the most common anxiety diagnosis — there are essentially no gabapentin trials; the stronger GAD evidence in this drug family belongs to its cousin pregabalin, not gabapentin. A 2022 systematic review found gabapentinoids beat placebo across several anxiety conditions but cautioned that their obvious side effects can unblind trials and overestimate the benefit, concluding the drugs should be used only 'with strong justification.' Bottom line: possibly useful in specific, mostly short-term situations, but far from an established anxiety treatment.

How it's used off-label

There is no FDA-approved gabapentin dose for anxiety — any regimen is off-label and chosen by the prescriber. For context, the social-anxiety trial used 900–3,600 mg per day split into three doses, and clinicians commonly start low (for example 100–300 mg at night) and titrate up gradually to limit dizziness and drowsiness. Because gabapentin is cleared by the kidneys, doses are reduced when kidney function is impaired. These figures are background, not medical advice: whether gabapentin is appropriate at all, and at what dose, must be individualized by a clinician. Never start, change, or stop it on your own.

Risks and cautions

The most common effects are dizziness, drowsiness and unsteadiness, which raise the risk of falls in older adults. In December 2019 the FDA warned that gabapentin can cause serious, even life-threatening breathing problems (respiratory depression) in people who also take opioids or other CNS depressants, in those with reduced lung function such as COPD, and in the elderly; the FDA linked 49 respiratory-depression cases from 2012–2017 to gabapentinoids (risk appears lower for otherwise healthy people using gabapentin alone). Gabapentin also carries misuse and dependence potential — concern has grown enough that several U.S. states classify it as a Schedule V controlled substance, though it is not federally scheduled. Do not stop it abruptly: sudden discontinuation can trigger withdrawal (anxiety, insomnia, nausea, sweating, pain) and, rarely, seizures, so it must be tapered under medical supervision. Antiepileptic drugs including gabapentin also carry an FDA warning about a small increased risk of suicidal thoughts or behavior, so mood changes should be monitored.

What’s actually FDA-approved for anxiety

If you want an evidence-based anxiety treatment, several drugs are genuinely FDA-approved for anxiety disorders. SSRIs (for example escitalopram/Lexapro, sertraline/Zoloft, paroxetine/Paxil) and SNRIs (venlafaxine XR/Effexor XR, duloxetine/Cymbalta) are first-line for ongoing anxiety and are not habit-forming, though they take a few weeks to work and carry a boxed warning about suicidal thoughts in people under 25. Buspirone is approved for generalized anxiety and is non-sedating. Benzodiazepines (such as alprazolam or lorazepam) act within hours but are for short-term use only because of dependence, and hydroxyzine is a non-addictive as-needed option. A prescriber can weigh these better-studied choices against off-label gabapentin.

Bottom line

Gabapentin is not FDA-approved for anxiety and is not a first-line treatment. The evidence is limited — modest support for social anxiety and short-term pre-surgery nerves, little to none for generalized anxiety. It may help selected patients under a doctor's care, but it carries real risks: sedation, dependence and withdrawal that require a taper, and a 2019 FDA warning about serious breathing problems when combined with opioids or other sedatives. For most people with an anxiety disorder, an FDA-approved option such as an SSRI, SNRI or buspirone is the better-studied place to start. Any decision about gabapentin should be made with a prescriber, not self-directed.

Frequently asked questions

Does gabapentin help anxiety?

Sometimes, in specific situations, but the evidence is limited and gabapentin is not FDA-approved for anxiety. The best data are for social anxiety disorder (one small placebo-controlled trial) and short-term anxiety before surgery. For generalized anxiety disorder there are essentially no gabapentin trials, and treatment guidelines do not list it as a first-line anxiety medication.

How much gabapentin for anxiety?

There is no FDA-approved dose for anxiety; any dose is off-label and set by a prescriber. The social-anxiety study used 900–3,600 mg per day in three divided doses, and clinicians often start low and titrate up to limit dizziness and drowsiness. Doses are lowered in people with reduced kidney function. Use only the regimen your clinician prescribes — these numbers are not a recommendation.

Is gabapentin addictive?

Gabapentin can be misused and can cause physical dependence. Concern has grown enough that several U.S. states now classify it as a Schedule V controlled substance, although it is not federally scheduled. Risk is higher in people with a history of substance misuse or who also take opioids. Because dependence can develop, gabapentin should not be stopped abruptly.

Gabapentin vs pregabalin for anxiety?

They are chemical cousins. Pregabalin (Lyrica) has stronger anxiety evidence and is approved for generalized anxiety disorder in Europe — but it is not FDA-approved for anxiety in the U.S., where it is a federally controlled Schedule V drug. Gabapentin has weaker evidence (mostly social anxiety and perioperative) and is not federally scheduled, though some states schedule it. In the U.S., both are off-label for anxiety, and a prescriber weighs the trade-offs.

How long does gabapentin take to work for anxiety?

Gabapentin acts on the nervous system relatively quickly, so calming or sedating effects can appear within hours to days — unlike SSRIs, which take several weeks. But fast, short-term sedation is not the same as treating an anxiety disorder, and there is little evidence gabapentin controls chronic anxiety over the long term. Any benefit and dose should be assessed with your prescriber.

Can you stop gabapentin suddenly?

No. Stopping gabapentin abruptly can cause withdrawal symptoms — anxiety, trouble sleeping, nausea, sweating and pain — and, rarely, seizures, even in people who do not have epilepsy. The dose should be lowered gradually (tapered) under medical supervision. Do not stop on your own.

Sources

More guides for Gabapentin

Gabapentin dosage→Gabapentin withdrawal→Does Gabapentin cause weight gain?→Gabapentin in pregnancy→

More off-label uses: Trazodone for insomnia · Propranolol for anxiety · Spironolactone for acne · Metformin for PCOS · Amitriptyline for insomnia.

This is general reference information, not medical advice. Off-label prescribing is legal and common, but whether a drug is right for you — on-label or off — is a decision for you and a licensed prescriber. Do not start, stop or change a medication based on this page.